Sections View Full Chapter Figures Tables Videos Annotate Full Chapter Figures Tables Videos Supplementary Content + • Associated with chronic pancreatitis and extensive pancreatic resections• Fat malabsorption and steatorrhea are the principal symptoms +++ Epidemiology + • Pancreatic insufficiency may be a sequelae of pancreatectomy or pancreatic disease, particularly chronic pancreatitis• The principal problems in otherwise uncomplicated pancreatic insufficiency is fat malabsorption, steatorrhea, and accompanying caloric malnutrition, which do not appear until loss of > 90% of pancreatic exocrine function• Total pancreatectomy causes about 70% fat malabsorption; if the pancreatic remnant is normal, subtotal resections may have little effect on absorption• Pancreatic insufficiency affects fat absorption more than protein or carbohydrate• Malabsorption of vitamins is rarely a significant problem; fat-soluble vitamins do not require pancreatic enzymes for absorption +++ Symptoms and Signs + • Fat malabsorption and steatorrhea• Diarrhea may or may not be present• Weight loss may occur from caloric malnutrition• Signs and symptoms of underlying disease process (chronic pancreatitis) +++ Laboratory Findings + • Exam of a stool specimen for fat globules is specific and relatively sensitive for fat malabsorption + • Secretin or cholecystokinin test: Measures HCO3 concentration in pancreatic juice following administration of either secretin or cholecystokinin• Pancreolauryl test: Fluorescein, release and absorption of which is dependent on pancreatic esterase, is given and urinary excretion is measured• PABA excretion (bentiromide) test: Bentiromide, cleaved by chymotrypsin to release PABA, is administered and urinary excretion of PABA is measured• Fecal fat balance test: After ingesting a diet containing 75-100 g of fat, the amount of dietary fat is measured + • Fecal fat determination• Other tests of pancreatic exocrine function if diagnosis remains unclear• Appropriate diagnosis of underlying disease process +++ When to Admit + • Severe malnutrition + • The diet should aim for 3000-6000 kcal/d, emphasizing carbohydrate (400 g or more) and protein (100-150 g); dietary restriction of fat is important mainly to control diarrhea +++ Surgery +++ Indications + • No surgical intervention indicated +++ Medications + • Pancrelipase replacement• H2 receptor blockers to retard gastric acid destruction of lipase• Medium-chain triglycerides (MCT) +++ Complications + • Fat malnutrition +++ Prognosis + • Symptoms often improve with pancreatic enzyme replacement +++ References ++DiMagno EP. Gastric acid suppression and treatment of severe exocrine pancreatic insufficiency. Best Pract Res Clin Gastroenterol. 2001;15:477. [PubMed: 11403540] ++Layer P, Keller J. Pancreatic enzymes: secretion and luminal nutrient digestion in health and disease. J Clin Gastroenterol. 1999;28:3. [PubMed: 9916657] Your Access profile is currently affiliated with [InstitutionA] and is in the process of switching affiliations to [InstitutionB]. Please select how you would like to proceed. Keep the current affiliation with [InstitutionA] and continue with the Access profile sign in process Switch affiliation to [InstitutionB] and continue with the Access profile sign in process Get Free Access Through Your Institution Learn how to see if your library subscribes to McGraw Hill Medical products. Subscribe: Institutional or Individual Sign In Error: Incorrect UserName or Password Username Error: Please enter User Name Password Error: Please enter Password Sign in Forgot Password? Forgot Username? Sign in via OpenAthens Sign in via Shibboleth You already have access! Please proceed to your institution's subscription. Create a free profile for additional features.